| Symbol | VRSEF |
|---|---|
| Name | VERISANTE TECHNOLOGY, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V6B 274 Canada BC 170 - 422 Richards Street |
| Telephone | 604-716-5133 |
| Fax | — |
| — | |
| Website | http://www.verisante.com |
| Incorporation | CA |
| Incorporated On | 2006 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Fernandez Young LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: TSX Venture Exchange |
| CIK | — |
| Description | Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer. Our exclusive platform technology allows us to develop and offer a range of compact, non-invasive cancer detection devices that offer immediate results for many of the most common cancers including skin, lung, gastrointestinal, cervical and colorectal. Additional info from OTC: |
Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: VERISANTE TECHNOLOGY INC.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: VERISANTE TECHNOLOGY INC.
Read more